Natus Medical Inc (BABY) announced its most recent quarterly financial results on Wednesday, Oct-19-2016. BABY said it had a profit of $0.39 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.05. Analysts had a consensus of $0.34. The company posted revenue of $90.90 million in the period, compared to analysts expectations of $89.94 million. BABY’s revenue was down -3.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.39 EPS.
Many Wall Street Analysts have commented on Natus Medical Inc. The Benchmark Company Initiated Natus Medical Inc on Oct 4, 2016 to “Buy”, Price Target of the shares are set at $55.Natus Medical Inc was Upgraded by Raymond James to ” Outperform” on Sep 13, 2016.
Natus Medical Inc closed down -0.15 points or -0.37% at $40.65 with 1,84,496 shares getting traded on Friday. Post opening the session at $41.05, the shares hit an intraday low of $40.25 and an intraday high of $41.05 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
In a different news, on Sep 28, 2016, James B Hawkins (CEO) purchased 10,000 shares at $38.48 per share price. According to the SEC, on Apr 28, 2016, Robert A Gunst (director) sold 5,000 shares at $34.61 per share price. On Apr 28, 2016, Doris Engibous (director) sold 5,000 shares at $32.68 per share price, according to the Form-4 filing with the securities and exchange commission.
Natus Medical Incorporated (Natus) is a provider of newborn care and neurology healthcare products and services used for the screening diagnosis detection treatment monitoring and tracking of common medical ailments in newborn care hearing impairment neurological dysfunction epilepsy sleep disorders and balance and mobility disorders. The Company offers two product families: Neurology which includes products and services for diagnostic electroencephalography and long term monitoring intensive care unit monitoring electromyography sleep analysis intra-operative monitoring and diagnostic and monitoring transcranial doppler ultrasound technology; and Newborn Care which includes products and services for newborn care including hearing screening brain injury thermoregulation jaundice management and various disposable products as well as products for diagnostic hearing assessment for children through adult populations and others.